• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病气流受限的结构基础

Structural basis for airflow limitation in chronic obstructive pulmonary disease.

作者信息

Saetta M, Turato G, Zuin R

机构信息

Dipartimento di Medicina Ambientale e Sanità Pubblica, Università degli Studi di Padova, Italy.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2000 Oct;17(3):239-45.

PMID:11033839
Abstract

The airflow limitation that characterises chronic obstructive pulmonary disease (COPD) has two main components: an increased resistance, which is due to airway obstruction, and a loss of the elastic recoil pressure of the lung, which is due to parenchymal destruction. Although it has long been known that the major site of increased resistance in COPD is the peripheral airways, recent studies have shown that central airways are involved in the disease as well. The purpose of this review is to describe the major structural and cellular changes present in peripheral airways, central airways and lung parenchyma of patients with COPD, and to underline the possible mechanisms contributing to airflow limitation in these subjects.

摘要

以慢性阻塞性肺疾病(COPD)为特征的气流受限有两个主要组成部分:一是阻力增加,这是由气道阻塞所致;二是肺弹性回缩压丧失,这是由实质破坏所致。尽管长期以来人们都知道COPD中阻力增加的主要部位是外周气道,但最近的研究表明中央气道也参与了该疾病。本综述的目的是描述COPD患者外周气道、中央气道和肺实质中存在的主要结构和细胞变化,并强调这些患者气流受限的可能机制。

相似文献

1
Structural basis for airflow limitation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病气流受限的结构基础
Sarcoidosis Vasc Diffuse Lung Dis. 2000 Oct;17(3):239-45.
2
Pathogenesis and pathology of COPD.
Respiration. 2001;68(2):117-28. doi: 10.1159/000050478.
3
Pathophysiology of the small airways in chronic obstructive pulmonary disease.慢性阻塞性肺疾病小气道的病理生理学。
Respiration. 2012;84(2):89-97. doi: 10.1159/000341382. Epub 2012 Aug 6.
4
Morphological and cellular basis for airflow limitation in smokers.吸烟者气流受限的形态学和细胞基础。
Eur Respir J. 1994 Aug;7(8):1505-15. doi: 10.1183/09031936.94.07081505.
5
Disease of the airways in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道疾病
Eur Respir J Suppl. 2001 Dec;34:41s-49s. doi: 10.1183/09031936.01.00234601.
6
Pathophysiology of obstructive airways disease.
Radiol Clin North Am. 1998 Jan;36(1):15-27. doi: 10.1016/s0033-8389(05)70005-1.
7
Pathology of emphysema in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中肺气肿的病理学
Monaldi Arch Chest Dis. 2000 Apr;55(2):124-9.
8
The pathology of small airways in chronic airflow limitation.慢性气流受限中小气道的病理学
Eur J Respir Dis Suppl. 1982;121:9-18.
9
Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology.慢性阻塞性肺疾病:气流受限结构决定因素的定义及其对流行病学的影响
Am Rev Respir Dis. 1989 Sep;140(3 Pt 2):S3-8. doi: 10.1164/ajrccm/140.3_Pt_2.S3.
10
Pathogenesis of COPD.慢性阻塞性肺疾病的发病机制
Semin Respir Crit Care Med. 2005 Apr;26(2):142-53. doi: 10.1055/s-2005-869535.

引用本文的文献

1
Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers.蛋白酶激活受体-2(PAR-2)在吸烟者和非吸烟者中央气道中的表达。
Thorax. 2002 Feb;57(2):146-51. doi: 10.1136/thorax.57.2.146.